Clinical trial
An Investigational Vaccine in Reducing the Incidence of Anogenital Warts in Young Men
NCT00090285 is registered in ClinicalTrials.gov with Merck Sharp & Dohme LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Investigational Vaccine in Reducing the Incidence of Anogenital Warts in Young Men
- Lead sponsor
- Merck Sharp & Dohme LLC
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 3, 2004
- Completion date
- April 3, 2017
- Enrollment
- 4,065 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.